Immuneering to Present at the Piper Sandler 36 Annual Healthcare Conference
CAMBRIDGE, Mass., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
November 27, 2024 08:00 ET | Source: CytomX Therapeutics Inc. SOUTH SAN…
WellRithms Co-founder and President, Anna Quarum, Honored at the 17th Annual 2024 Globee Awards for Achievement Women in Business
PORTLAND, Ore., Nov. 26, 2024 (GLOBE NEWSWIRE) -- WellRithms, an industry-leading payment…
GoldenTV and Character Media Announce 22nd Annual Unforgettable Gala Honorees
–2024 Honorees include Cast, Creatives of Avatar: The Last Airbender, Dìdi, Shōgun,…
Rakovina Therapeutics Announces Upcoming Poster Presentation at the 29th Annual Society for Neuro-Oncology Meeting in Houston, Texas
November 20, 2024 16:30 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
GREATER DES MOINES PARTNERSHIP ANNUAL DINNER SPEAKER ANNOUNCED
GREATER DES MOINES, Iowa, Nov. 20, 2024 /PRNewswire/ -- The Greater Des…
TELA Bio to Participate in Piper Sandlers 36th Annual Healthcare Conference
November 19, 2024 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…
Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology
November 15, 2024 17:52 ET | Source: Protara Therapeutics NEW YORK, Nov.…
A2 Bio Highlights Progress of Tmod CAR T-Cell Clinical Programs During 2024 Annual Meeting of the Society for Immunotherapy of Cancer
Oral presentation provides update on enhancements to improve participant diversity and enrollment…
Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting
Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on…